Outset Medical (OM) EBITDA Margin (2019 - 2026)
Outset Medical's (OM) quarterly EBITDA Margin came in at 49.55% in Q2 2026, up 413.0% year-over-year from 9.66% in Q2 2025, and up 18.39% quarter-over-quarter from 60.72% in Q1 2026.
Powered by 
Analysis
Outset Medical (OM) EBITDA Margin (2019 - 2026) Analysis & Trends
Outset Medical (OM) has reported EBITDA Margin for 8 consecutive years, with 49.55% the latest figure, recorded in Q2 2026.
- On a quarterly basis, EBITDA Margin rose 413.0% year-over-year to 49.55% in Q2 2026; TTM through Jun 2026 was 56.06%, a 1013.0% increase from a year earlier, with the FY2025 full-year figure at 55.83%, up 4389.0% from the prior year.
- EBITDA Margin was 49.55% for Q2 2026 at Outset Medical, up from 60.72% in the prior quarter.
- Over five years, EBITDA Margin peaked at 49.55% in Q2 2026 and troughed at 174.49% in Q2 2022.
- A 5-year average of 101.29% and a median of 115.86% in 2022 frame the typical range for EBITDA Margin.
- Across the five-year window, EBITDA Margin slumped 5589 bps in 2022 and jumped 7592 bps in 2025, its largest moves.
- Over 5 years, EBITDA Margin stood at 124.42% in 2022, then rose by 2 bps to 122.44% in 2023, then surged by 39 bps to 74.18% in 2024, then increased by 18 bps to 61.05% in 2025, then advanced by 19 bps to 49.55% in 2026.
- The last three EBITDA Margin figures came in at 49.55% (Q2 2026), 60.72% (Q1 2026), and 61.05% (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 179.79 Bn | 174.18 Bn | 7.27 Bn | 13.44% |
| 2 | Intuitive Surgical | 127.69 Bn | 122.47 Bn | 1.96 Bn | 33.60% |
| 3 | Medtronic | 117.23 Bn | 108.41 Bn | 6.34 Bn | 18.08% |
| 4 | Stryker | 103.55 Bn | 100.07 Bn | 4.50 Bn | 25.18% |
| 5 | Boston Scientific | 63.24 Bn | 62.70 Bn | 3.85 Bn | 21.65% |
| 6 | Edwards Lifesciences | 49.97 Bn | 45.72 Bn | 1.35 Bn | 29.48% |
| 7 | Alcon | 32.83 Bn | 31.37 Bn | 1.68 Bn | 0.40% |
| 8 | Dexcom | 32.30 Bn | 30.35 Bn | 830.00 Mn | 24.33% |
| 9 | Steris | 20.73 Bn | 20.25 Bn | 684.20 Mn | 19.15% |
| 10 | Outset Medical | 60.51 Mn | -202.68 Mn | 13.28 Mn | -49.55% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -49.55% |
| Mar 31, 2026 | -60.72% |
| Dec 31, 2025 | -61.05% |
| Sep 30, 2025 | -53.73% |
| Jun 30, 2025 | -53.68% |
| Mar 31, 2025 | -55.12% |
| Dec 31, 2024 | -74.18% |
| Sep 30, 2024 | -83.16% |
| Jun 30, 2024 | -112.33% |
| Mar 31, 2024 | -131.04% |
| Dec 31, 2023 | -122.44% |
| Sep 30, 2023 | -149.71% |
| Jun 30, 2023 | -120.64% |
| Mar 31, 2023 | -129.93% |
| Dec 31, 2022 | -124.42% |
| Sep 30, 2022 | -147.69% |
| Jun 30, 2022 | -174.49% |
| Mar 31, 2022 | -119.39% |
| Dec 31, 2021 | -144.92% |
| Sep 30, 2021 | -114.51% |